Release of anandamide from blood cells

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 4, 2006, Pages 488-491

  Vogeser, Michael ^a   Hauer, Daniela ^b   Azad, Shahnaz Christina ^b   Huber, Erasmus ^a   Storr, Martin ^a   Schelling, Gustav ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Anandamide (arachidonylethanolamide); Liquid chromatography tandem mass spectrometry; Preanalytical period

Indexed keywords

ANANDAMIDE; EDETIC ACID; ENDOCANNABINOID; HEPARIN;

ARTICLE; BLOOD CELL; BLOOD LEVEL; BLOOD SAMPLING; BLOOD STORAGE; CENTRIFUGATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ICOSANOID METABOLISM; ISOTOPE DILUTION ASSAY; LIQUID CHROMATOGRAPHY; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; TANDEM MASS SPECTROMETRY; TEMPERATURE DEPENDENCE; TIME; TRANSPORT KINETICS; TUBE; VOLUNTEER;

ARACHIDONIC ACIDS; BLOOD CELLS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; HUMANS; POLYUNSATURATED ALKAMIDES; TEMPERATURE; TIME FACTORS;

EID: 33645755897     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.065     Document Type: Article

References (31)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-4.
2. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-5.
3. Di Marzo, De Petrocellis VL, Fezza F, Ligresti A, Bisogno T. Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 2002;66:377-91.
4. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9.
5. Di Marzo V, Deutsch DG. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 1998;5:386-404.
6. Sugiura T, Waku K. Cannabinoid receptors and their endogenous ligands. J Biochem 2002;132:7-12.
7. Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002;66:101-21.
8. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003;83:1017-66.
9. Walker JM, Huang SM. Endocannabinoids in pain modulation. Prostaglandins Leukot Essent Fatty Acids 2002;66:235-42.
10. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004;13:2113-9.
11. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005;8:585-9.
12. Despres JP, Golay A, Sjostrom L, Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005;353:2121-34.
13. Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000;225:1-8.
14. Parolaro D, Massi P, Rubino T, Monti E. Endocannabinoids in the immune system and cancer. Prostaglandins Leukot Essent Fatty Acids 2002;66:319-32.
15. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003;74:486-96.
16. Maccarrone M, Finazzi-Agro A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 2003;10:946-55.
17. Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, et al. Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. Thromb Haemost 2003;89:875-84.
18. Randall MD, Kendall DA. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol Sci 1998;19:55-8.
19. Wagner JA, Hu K, Bauersachs J, Karcher J, Wiesler M, Goparaju SK, et al. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J Am Coll Cardiol 2001;38:2048-54.
20. Wagner JA, Jarai Z, Batkai S, Kunos G. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 2001;423:203-10.
21. Sipe JC, Arbour N, Gerber A, Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 2005;78:231-8.
22. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996;384:83-7.
23. Cravatt BF, Lichtman AH. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 2003;7:469-75.
24. De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis 2003;2:5.
25. Obata T, Sakurai Y, Kase Y, Tanifuji Y, Horiguchi T. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and isoprostane (8-epiprostaglandin F2alpha) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003;792:131-40.
26. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuroreport 2003;14:2209-11.
27. Fernandez-Rodriguez CM, Romero J, Petros TJ, Bradshaw H, Gasalla JM, Gutierrez ML, et al. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis. Liver Int 2004; 24:477-83.
28. Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 2004;29:2108-14.
29. Habayeb OM, Taylor AH, Evans MD, Cooke MS, Taylor DJ, Bell SC, et al. Plasma levels of the endocannabinoid anandamide in women - a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab 2004;89:5482-7.
30. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 1997;272:3315-23.
31. Giuffrida AF, Piomelli D. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. FEBS Lett 1998;422:373-6.